95 related articles for article (PubMed ID: 8091394)
21. Pulmonary and neutrophil responses to priming effects of platelet-activating factor in pigs.
Kruse-Elliott KT
Am J Vet Res; 1997 Dec; 58(12):1386-91. PubMed ID: 9401686
[TBL] [Abstract][Full Text] [Related]
22. Involvement of platelet activating factor in immediate heart response to lipopolysaccharide.
Jakubowski A; Olszanecki R; Chlopicki S
J Physiol Pharmacol; 2004 Jun; 55(2):409-21. PubMed ID: 15213362
[TBL] [Abstract][Full Text] [Related]
23. Platelet activating factor impairs pressor responses to noradrenaline in the anaesthetized rat but does not mediate endotoxin-induced hyporeactivity.
Bouvier C; Guc MO; Furman BL; Parratt JR
Circ Shock; 1994 Jan; 42(1):14-9. PubMed ID: 8149505
[TBL] [Abstract][Full Text] [Related]
24. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
Porta C; Maiolo A; Tua A; Grignani G
Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928
[TBL] [Abstract][Full Text] [Related]
25. Biphasic response to lipopolysaccharide from E. coli in the isolated ventilated blood-perfused rat lung.
Chlopicki S; Bartuś JB; Gryglewski RJ
J Physiol Pharmacol; 1999 Dec; 50(4):551-65. PubMed ID: 10639006
[TBL] [Abstract][Full Text] [Related]
26. Effects of a new platelet-activating factor antagonist, UR-12670, on several endotoxic shock markers in rats.
Balsa D; Merlos M; Giral M; Ferrando R; Garcia-Rafanell J; Forn J
Drugs Exp Clin Res; 1997; 23(5-6):191-9. PubMed ID: 9515229
[TBL] [Abstract][Full Text] [Related]
27. [The effects of platelet-activating factor (PAF) on the collagen-induced whole blood aggregation].
Oura Y
Rinsho Byori; 1994 Jan; 42(1):63-9. PubMed ID: 8107285
[TBL] [Abstract][Full Text] [Related]
28. Shape change in human platelets: measurement with a channelyzer and visualisation by electron microscopy.
Jagroop IA; Clatworthy I; Lewin J; Mikhailidis DP
Platelets; 2000 Feb; 11(1):28-32. PubMed ID: 10938878
[TBL] [Abstract][Full Text] [Related]
29. Endotoxin receptor site. II. Specificity of endotoxin receptor of platelets and sensitivity to endotoxin in vivo.
Washida S
Acta Med Okayama; 1978 Jul; 32(3):217-23. PubMed ID: 151487
[TBL] [Abstract][Full Text] [Related]
30. Radiation and primary response to lipopolysaccharide: bone marrow-derived cells and susceptible organs.
Gridley DS; Miller GM; Pecaut MJ
In Vivo; 2007; 21(3):453-61. PubMed ID: 17591354
[TBL] [Abstract][Full Text] [Related]
31. Effects of endothelin-1 on aggregation of normal and uremic platelets.
Pawlak K; Małyszko JS; Małyszko J; Myśliwiec M
Pol J Pharmacol; 1996; 48(2):185-90. PubMed ID: 9112649
[TBL] [Abstract][Full Text] [Related]
32. [Measurement of platelet volume: methodologic approach and application in diabetes].
Facquet-Danis J; Scarabin PY; Dumoulin-Lagrange M; Ravoisier N; Samama M
Nouv Rev Fr Hematol (1978); 1982; 24(2):69-73. PubMed ID: 7111015
[TBL] [Abstract][Full Text] [Related]
33. Endotoxins stimulate generation of superoxide radicals and lipid peroxidation in blood platelets.
Saluk-Juszczak J; Wachowicz B; Kaca W
Microbios; 2000; 103(404):17-25. PubMed ID: 11034442
[TBL] [Abstract][Full Text] [Related]
34. Influence of preparative procedures on assay of platelet function and apparent effects of antiplatelet agents.
Madsen NJ; Holmes CE; Serrano FA; Sobel BE; Schneider DJ
Am J Cardiol; 2007 Aug; 100(4):722-7. PubMed ID: 17697836
[TBL] [Abstract][Full Text] [Related]
35. Induction of tissue factor expression in whole blood: lack of evidence for the presence of tissue factor expression in granulocytes.
Osterud B; Rao LV; Olsen JO
Thromb Haemost; 2000 Jun; 83(6):861-7. PubMed ID: 10896239
[TBL] [Abstract][Full Text] [Related]
36. Actions and interactions of ADP, 5- HT, histamine and PAF on equine platelets.
Bailey SR; Andrews MJ; Elliott J; Cunningham F
Res Vet Sci; 2000 Apr; 68(2):175-80. PubMed ID: 10756136
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of factors that can modify platelet-rich plasma properties.
Andrade MG; de Freitas Brandão CJ; Sá CN; de Bittencourt TC; Sadigursky M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jan; 105(1):e5-e12. PubMed ID: 18155603
[TBL] [Abstract][Full Text] [Related]
38. Platelet-activating factor mediates Porphyromonas gingivalis lipopolysaccharide interference with salivary mucin synthesis via phosphatidylinositol 3-kinase-dependent constitutive nitric-oxide synthase activation.
Slomiany BL; Slomiany A
J Physiol Pharmacol; 2004 Mar; 55(1 Pt 1):85-98. PubMed ID: 15082869
[TBL] [Abstract][Full Text] [Related]
39. Platelet aggregating response to platelet activating factor participates in activation of the 12-lipoxygenase pathway in platelets from rabbits.
Michibayashi T
Int Angiol; 2002 Sep; 21(3):260-7. PubMed ID: 12384648
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
